Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H27NO |
Molecular Weight | 369.4987 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C(=O)C2=CC=C(CC)C3=C2C=CC=C3)C4=C1C=CC=C4
InChI
InChIKey=LACIUQLUNACUKC-UHFFFAOYSA-N
InChI=1S/C26H27NO/c1-3-5-10-17-27-18-24(22-13-8-9-14-25(22)27)26(28)23-16-15-19(4-2)20-11-6-7-12-21(20)23/h6-9,11-16,18H,3-5,10,17H2,1-2H3
Molecular Formula | C26H27NO |
Molecular Weight | 369.4987 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26535086Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19249138 | https://www.ncbi.nlm.nih.gov/pubmed/28828742
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26535086
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19249138 | https://www.ncbi.nlm.nih.gov/pubmed/28828742
JWH-210 is an analgesic chemical from the naphthoylindole family, which acts as a potent cannabinoid agonist at both the CB1 and CB2 receptors. JWH-210 is one of the most potent 4-substituted naphthoyl derivatives in the naphthoylindole series, having a higher binding affinity. The physiological and toxicological properties of this compound have not been evaluated in humans.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26535086 | https://www.ncbi.nlm.nih.gov/pubmed/27834143
Curator's Comment: Known to be CNS penetrant in Pigs, Mice. Human data not available.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19249138 |
0.46 nM [Ki] | ||
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19249138 |
0.69 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28828742
Mice were treated with JWH-210 (10 mg/kg, 3 days, i.p.)
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28828742
Splenocytes were cultured from naïve mice as mentioned previously. The cells were seeded in 96-well plates (5 × 10^5 cells/ well) with 100 μL media. After seeding single cell suspensions, the plates were incubated for 6 h in 95% air:5% CO2 using standard culture methods. To confirm cell viability by synthetic cannabinoids, the splenocytes were treated with synthetic cannabinoids (0, 1, 10, and 100 μM) for 16 h. To observe relationship between JWH-210 and CB receptors, the splenocytes were treated with media or JWH-210 or JWH-210/CB receptor antagonist (rimonabant or AM630) for 4 h.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:40:34 GMT 2023
by
admin
on
Sat Dec 16 08:40:34 GMT 2023
|
Record UNII |
R18JYO04PY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-JWH-210
Created by
admin on Sat Dec 16 08:40:34 GMT 2023 , Edited by admin on Sat Dec 16 08:40:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID301010019
Created by
admin on Sat Dec 16 08:40:34 GMT 2023 , Edited by admin on Sat Dec 16 08:40:34 GMT 2023
|
PRIMARY | |||
|
45270396
Created by
admin on Sat Dec 16 08:40:34 GMT 2023 , Edited by admin on Sat Dec 16 08:40:34 GMT 2023
|
PRIMARY | |||
|
824959-81-1
Created by
admin on Sat Dec 16 08:40:34 GMT 2023 , Edited by admin on Sat Dec 16 08:40:34 GMT 2023
|
PRIMARY | |||
|
JWH-210
Created by
admin on Sat Dec 16 08:40:34 GMT 2023 , Edited by admin on Sat Dec 16 08:40:34 GMT 2023
|
PRIMARY | |||
|
R18JYO04PY
Created by
admin on Sat Dec 16 08:40:34 GMT 2023 , Edited by admin on Sat Dec 16 08:40:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |